author-photo

Debra Wyatt

Loyola University Chicago

16

Papers

605

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

Abstract 1859: Elucidating the role of KMT2D as a novel therapeutic target for resistant HER2+ breast cancer

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
DAXX-inducing phytoestrogens inhibit ER+ tumor initiating cells and delay tumor development.

2020
Show All
- Source
- Cite
- Save
Citations (6)
DAXX Suppresses Tumor-Initiating Cells in Estrogen Receptor-positive Breast Cancer following endocrine therapy

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (19)
Preclinical study of a Kv11.1 potassium channel activator as antineoplastic approach for breast cancer

2018 Oncotarget
Show All
- Source
- Cite
- Save
Citations (23)
Inhibition of HER2 Increases JAGGED1-dependent Breast Cancer Stem Cells: Role for Membrane JAGGED1

2018 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (17)
Abstract 1831: PKCδ as a novel target for HER2-positive, trastuzumab resistant breast cancer

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 4769: Targeting HER2 enriches Jagged1 high cancer stem cells in breast cancer

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract LB-121: DAXX is a novel Notch-1 gene target and biomarker of GSI-sensitivity in ER+ breast cancer

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1823: Novel regulation of Jagged1 by ErbB2 in breast cancer: implications for anti-ErbB2 therapy

2014 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Cross-talk between Notch and the Estrogen Receptor in Breast Cancer Suggests Novel Therapeutic Approaches

2008 Cancer Research
Show All
- Source
- Cite
- Save
Citations (300)